Industry Perspectives

Biotium launches GlycoLiner kits for rapid and selective cell surface labeling

New GlycoLiner kits enable rapid, covalent labeling of live-cell surface glycoproteins using gentle, self-catalyzing chemistry at neutral pH.
Written byBiotium
| 2 min read
Live HeLa cells labeled with GlycoLiner™ Reactive Biotin detected with CF®488A streptavidin, or GlycoLiner™ Reactive Dyes, imaged by confocal microscopy using a 40X objective.

Live HeLa cells labeled with GlycoLiner™ Reactive Biotin detected with CF®488A streptavidin, or GlycoLiner™ Reactive Dyes, imaged by confocal microscopy using a 40X objective.

CREDIT: Biotium

Register for free to listen to this article
Listen with Speechify
0:00
2:00

FREMONT, CA, January 02, 2026 / Biotech Newswire / -- Biotium, a leading innovator in fluorescent dyes and life science reagents, announces the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins. Unlike conventional aminooxy reagents that are slow to react and require harsh buffers, additional catalysts, or high label concentrations, GlycoLiner Kits utilize a simpler and more gentle self-catalyzing aminooxy chemistry for efficient labeling at neutral pH.

Surface labeling can be completed in ~20 minutes at room temperature or 4°C, supporting workflows that require low-temperature conditions to prevent protein internalization. Labels include biotin or a selection of five bright fluorescent dyes.

GlycoLiner labeling is covalent and compatible with common fixation and permeabilization protocols or protein extraction for capture of biotinylated glycoproteins, enabling downstream immunofluorescence staining, microscopy, flow cytometry, or biochemical analysis. GlycoLiner also produces noticeably reduced intracellular staining in dead cells, enabling clearer visualization of cell boundaries compared to other covalent cell surface stains that can strongly label dead cell cytoplasm.

“Biotium has launched an extensive selection of unique membrane-labeling probes that support different workflows. We are excited to provide yet another option that offers highly selective imaging of live cell surface glycoproteins that is also compatible with fixation,” said Lori Roberts, Director of Bioscience at Biotium.

Key Features

  • Fast, simple, and gentle: Labels cell surface glycoproteins for imaging or protein analysis
  • Highly selective live-cell surface labeling: Lower dead-cell background than other covalent stains
  • Compatible with fixation, permeabilization, and cell lysis: Ideal for downstream imaging or analysis
  • Novel self-catalyzing reaction: Efficient labeling at neutral pH without a catalyst
  • Versatile labeling options: Choose from 5 fluorescent dyes from blue to near-IR, or biotin
  • Efficient workflow: Complete in ~20 minutes

GlycoLiner expands Biotium’s portfolio of innovative cell staining technologies, offering researchers a powerful new tool for cell surface biology research with clarity and precision. Learn more about Biotium’s expanding catalog of unique membrane and cell surface stains, including options for staining fixed cells, or long-term imaging in live cells.

GlycoLiner Kits are now available through Biotium and authorized distributors worldwide.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Abstract illustration of colorful spectral emission peaks.
As flow cytometry panels grow larger and more complex, thoughtful panel design has become critical for experimental success.
A scientist in a white lab coat looking into a microscope in a brightly lit modern laboratory.
Learn how developmental and reproductive toxicology study selection supports regulatory decision-making and generates meaningful nonclinical safety data.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.